136 related articles for article (PubMed ID: 26916732)
1. Low Levels of Apolipoprotein B-100 Autoantibodies Are Associated With Increased Risk of Coronary Events.
Björkbacka H; Alm R; Persson M; Hedblad B; Nilsson J; Fredrikson GN
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):765-71. PubMed ID: 26916732
[TBL] [Abstract][Full Text] [Related]
2. Relationship of Autoantibodies to MDA-LDL and ApoB-Immune Complexes to Sex, Ethnicity, Subclinical Atherosclerosis, and Cardiovascular Events.
Prasad A; Clopton P; Ayers C; Khera A; de Lemos JA; Witztum JL; Tsimikas S
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1213-1221. PubMed ID: 28473443
[TBL] [Abstract][Full Text] [Related]
3. Circulating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old women.
Fagerberg B; Prahl Gullberg U; Alm R; Nilsson J; Fredrikson GN
PLoS One; 2015; 10(3):e0120744. PubMed ID: 25768285
[TBL] [Abstract][Full Text] [Related]
4. Low levels of IgG autoantibodies against the apolipoprotein B antigen p210 increases the risk of cardiovascular death after carotid endarterectomy.
Asciutto G; Dias NV; Edsfeldt A; Alm R; Fredrikson GN; Gonçalves I; Nilsson J
Atherosclerosis; 2015 Apr; 239(2):289-94. PubMed ID: 25682025
[TBL] [Abstract][Full Text] [Related]
5. High levels of autoantibodies against apoB100 p210 are associated with lower incidence of atrial fibrillation in women.
Sveen KA; Smith G; Björkbacka H; Orho-Melander M; Engström G; Gonçalves I; Melander O; Nilsson J; Bengtsson E
J Intern Med; 2022 Feb; 291(2):207-217. PubMed ID: 34532909
[TBL] [Abstract][Full Text] [Related]
6. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events.
Tsimikas S; Brilakis ES; Lennon RJ; Miller ER; Witztum JL; McConnell JP; Kornman KS; Berger PB
J Lipid Res; 2007 Feb; 48(2):425-33. PubMed ID: 17093289
[TBL] [Abstract][Full Text] [Related]
7. Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population.
Antiochos P; Marques-Vidal P; Virzi J; Pagano S; Satta N; Hartley O; Montecucco F; Mach F; Kutalik Z; Waeber G; Vollenweider P; Vuilleumier N
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2342-2349. PubMed ID: 29074586
[TBL] [Abstract][Full Text] [Related]
8. Low Levels of IgM Antibodies against an Advanced Glycation Endproduct-Modified Apolipoprotein B100 Peptide Predict Cardiovascular Events in Nondiabetic Subjects.
Engelbertsen D; Vallejo J; Quách TD; Fredrikson GN; Alm R; Hedblad B; Björkbacka H; Rothstein TL; Nilsson J; Bengtsson E
J Immunol; 2015 Oct; 195(7):3020-5. PubMed ID: 26290603
[TBL] [Abstract][Full Text] [Related]
9. Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes.
Fredrikson GN; Anand DV; Hopkins D; Corder R; Alm R; Bengtsson E; Shah PK; Lahiri A; Nilsson J
Diabetologia; 2009 Jul; 52(7):1426-33. PubMed ID: 19448981
[TBL] [Abstract][Full Text] [Related]
10. Plasma autoantibodies against apolipoprotein B-100 peptide 210 in subclinical atherosclerosis.
McLeod O; Silveira A; Fredrikson GN; Gertow K; Baldassarre D; Veglia F; Sennblad B; Strawbridge RJ; Larsson M; Leander K; Gigante B; Kauhanen J; Rauramaa R; Smit AJ; Mannarino E; Giral P; Humphries SE; Tremoli E; de Faire U; Ohrvik J; Nilsson J; Hamsten A
Atherosclerosis; 2014 Jan; 232(1):242-8. PubMed ID: 24401246
[TBL] [Abstract][Full Text] [Related]
11. Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.
Svenungsson E; Engelbertsen D; Wigren M; Gustafsson JT; Gunnarsson I; Elvin K; Jensen-Urstad K; Fredrikson GN; Nilsson J
Clin Exp Immunol; 2015 Sep; 181(3):417-26. PubMed ID: 25959453
[TBL] [Abstract][Full Text] [Related]
12. High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction.
Sjögren P; Fredrikson GN; Samnegard A; Ericsson CG; Ohrvik J; Fisher RM; Nilsson J; Hamsten A
Eur Heart J; 2008 Sep; 29(18):2218-26. PubMed ID: 18664466
[TBL] [Abstract][Full Text] [Related]
13. Anti-ApoA-I IgG antibodies are not associated with carotid artery disease progression and first-time cardiovascular events in middle-aged individuals.
Lagerstedt JO; Dalla-Riva J; Marinkovic G; Del Giudice R; Engelbertsen D; Burlin J; Petrlova J; Lindahl M; Bernfur K; Melander O; Nilsson J; Schiopu A
J Intern Med; 2019 Jan; 285(1):49-58. PubMed ID: 30028049
[TBL] [Abstract][Full Text] [Related]
14. High levels of IgM against methylglyoxal-modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetes.
Engelbertsen D; Anand DV; Fredrikson GN; Hopkins D; Corder R; Shah PK; Lahiri A; Nilsson J; Bengtsson E
J Intern Med; 2012 Jan; 271(1):82-9. PubMed ID: 21668821
[TBL] [Abstract][Full Text] [Related]
15. Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease.
Fredrikson GN; Hedblad B; Berglund G; Alm R; Nilsson JA; Schiopu A; Shah PK; Nilsson J
Stroke; 2007 May; 38(5):1495-500. PubMed ID: 17363723
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody against the amino acid sequence 661-680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events.
Fredrikson GN; Schiopu A; Berglund G; Alm R; Shah PK; Nilsson J
Atherosclerosis; 2007 Oct; 194(2):e188-92. PubMed ID: 17214995
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein B-100 Antibody Interaction With Atherosclerotic Plaque Inflammation and Repair Processes.
Asciutto G; Wigren M; Fredrikson GN; Mattisson IY; Grönberg C; Alm R; Björkbacka H; Dias NV; Edsfeldt A; Gonçalves I; Nilsson J
Stroke; 2016 Apr; 47(4):1140-3. PubMed ID: 26965851
[TBL] [Abstract][Full Text] [Related]
18. Long-term prognostic value of IgM antibodies against phosphorylcholine for adverse cardiovascular events in patients with stable coronary heart disease.
Imhof A; Koenig W; Jaensch A; Mons U; Brenner H; Rothenbacher D
Atherosclerosis; 2015 Dec; 243(2):414-20. PubMed ID: 26520895
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against aldehyde-modified collagen type IV are associated with risk of development of myocardial infarction.
Vallejo J; Dunér P; Fredrikson GN; Nilsson J; Bengtsson E
J Intern Med; 2017 Dec; 282(6):496-507. PubMed ID: 28944562
[TBL] [Abstract][Full Text] [Related]
20. Anti-Apo B-100 Autoantibody is a Marker of Unstable Coronary Plaque.
Imai M; Kawamura M; Kochi I; Matsuoka T; Kihara S; Yamamoto H
J Atheroscler Thromb; 2021 Oct; 28(10):1025-1034. PubMed ID: 33191364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
